Roche, Pfizer, Sanofi Plan $72.7 Million Stem-Cell Bank

Drug companies and universities are spending 55.6 million euros ($72.7 million) to develop a bank of stem cells to use in testing potential treatments for hard-to-treat diseases.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.